The United States market has shown a robust performance recently, climbing 2.2% in the last week and rising 25% over the past year, with earnings projected to grow by 19% annually. In this thriving environment, growth companies with significant insider ownership can be particularly appealing as they often indicate confidence from those closest to the business and align interests between management and shareholders.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Uxin (UXIN)	34.3%	74.1%
Upstart Holdings (UPST)	14.1%	58.5%
OS Therapies (OSTX)	12.4%	72.1%
Laird Superfood (LSF)	17%	109.9%
Karman Holdings (KRMN)	15.6%	52.6%
Forum Markets (FRMM)	32%	127.7%
Duos Technologies Group (DUOT)	11.2%	48.2%
Corcept Therapeutics (CORT)	10.9%	48.9%
Astera Labs (ALAB)	10%	29.3%
AppLovin (APP)	27.2%	21.7%

Here's a peek at a few of the choices from the screener.

Tesla (TSLA)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Tesla, Inc. is involved in designing, developing, manufacturing, leasing, and selling electric vehicles as well as energy generation and storage systems globally, with a market cap of approximately $1.53 trillion.

Operations: Tesla's revenue primarily comes from its automotive segment, generating $85.43 billion, and its energy generation and storage segment, contributing $12.45 billion.

Insider Ownership: 24.9%

Earnings Growth Forecast: 35.2% p.a.

Tesla, Inc. exemplifies a growth company with substantial insider ownership, navigating both opportunities and challenges. Earnings are expected to grow significantly at 35.2% annually, outpacing the US market's forecasted growth. However, Tesla's return on equity is projected to be relatively low at 10.3%. Recent developments include regulatory compliance for production in Texas and plans for advanced AI chip factories in Austin, signifying strategic expansion despite lower profit margins compared to last year.

Hinge Health (HNGE)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Hinge Health, Inc. develops a scalable and automated health system using technology, with a market cap of $5.06 billion.

Operations: The company's revenue primarily comes from its Healthcare Software segment, which generated $646.34 million.

Insider Ownership: 16.1%

Earnings Growth Forecast: 69.2% p.a.

Hinge Health exemplifies a growth company with high insider ownership, showing robust revenue growth of 49.8% over the past year and expected to grow faster than the US market at 19% annually. Recent expansions in its HingeSelect program for orthopedic surgery and migraine care signal strategic positioning in comprehensive musculoskeletal solutions. Despite low forecasted return on equity at 16.3%, Hinge Health's innovative offerings and cost-saving measures present significant potential for sustained market impact.

Victoria's Secret (VSXY)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Victoria's Secret & Co. is a global specialty retailer focusing on women's intimate apparel, other clothing, and beauty products, with a market cap of approximately $6.27 billion.

Operations: The company's revenue is primarily generated from its Retail - Specialty segment, which accounts for $6.76 billion.

Insider Ownership: 11.7%

Earnings Growth Forecast: 39.6% p.a.

Victoria's Secret exhibits characteristics of a growth company with significant insider ownership, despite high debt and volatile share price. The company's earnings are projected to grow at 39.56% annually, outpacing the US market. Recent first-quarter results showed substantial improvements, with net income reaching US$47.69 million compared to a loss last year. Insider activity indicates more shares bought than sold recently, reflecting confidence in its strategic "Path to Potential" plan amidst ongoing shareholder activism challenges.

Key Takeaways

• Click through to start exploring the rest of the 170 Fast Growing US Companies With High Insider Ownership now.
• Want To Explore Some Alternatives? Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.